Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic: The European Journal of Contraception & Reproductive Health Care: Vol 0, No 0
Abstract
Purpose
To evaluate the acceptance rate of post-placental intrauterine device (PPIUD) placement during the SARS-CoV-2 (COVID-19) pandemic and to assess factors associated with PPIUD acceptance.
Method
A cross-sectional study was conducted between August 2020 and August 2021. PPIUDs were offered to women scheduled for caesarean delivery or admitted in labor at the Women’s Hospital of the University of Campinas. The study compared women according to whether or not they accepted IUD placement. Factors associated with receiving PPIUD were analyzed by bivariate and multiple logistic regression analysis.
Results
We enrolled 299 women (15.9% of deliveries that occurred during the study period), aged 26.8 ± 6.5 years; 41.8% were White, nearly one-third were primiparous, and 155/299 (51.8%) had vaginal delivery. The acceptance rate of PPIUD is 65.6%. The main reason for refusal was the desire for another contraceptive (41.8%). Women with the highest odds of receiving PPIUD were younger (<30 years old had 1.7 more odds or 74% greater odds), singles (3.4 times more likely) and those who had just given birth vaginally (1.7 times more likely or 69% greater. )
Conclusion
COVID-19 does not affect PPIUD placement. PPIUD is a viable alternative in times of crisis where women find it difficult to access health services. Younger women, those who are single and after vaginal delivery are more likely to receive PPIUD during the COVID-19 pandemic.
SHORT CONDENSATION
Post-placental IUDs are an alternative in times of crisis such as the COVID-19 pandemic. Younger women, those who are single and after vaginal delivery are more likely to receive PPIUD during the COVID-19 pandemic.
Disclosure statement
Luis Bahamondes received an honorarium from Bayer Pharma as a speaker. The other authors declare no conflict of interest.
Reprints and Company Permissions
Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page
How do I view content?
To request reprint or company permissions for this article, please click on the relevant link below:
Academic Permissions
Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page How do I view content?
Get permissions instantly through Rightslink by clicking the button below:
If you are unable to obtain permissions through Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
